Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-030915
Filing Date
2014-05-02
Accepted
2014-05-02 19:51:33
Documents
2
Period of Report
2014-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10566
2 EX-24 DOCUMENT attachment1.htm EX-24 4113
  Complete submission text file 0001209191-14-030915.txt   15986
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Osborne, Jr. Charles F (Reporting) CIK: 0001604065 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36365 | Film No.: 14811007